News

Theravance Biopharma, Inc. announced that the first COVID-19 patient has been dosed in a Phase 2 study of TD-0903. TD-0903 is a lung-selective, nebulized Janus kinase inhibitor (JAKi)…
Read More...

Avalon GloboCare Corp. announced a strategic partnership with the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria to develop an S-layer vaccine that can be…
Read More...

Noxopharm, a clinical-stage Australian drug development company, has announced commencement of its NOXCOVID clinical program with a planned Phase I trial in Europe. This action is…
Read More...

Zogenix, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved FINTEPLA (fenfluramine) oral solution, CIV for the treatment of seizures associated with Dravet…
Read More...

Evotec SE, Samsara BioCapital, a leading life sciences investment firm, and KCK Ltd., a family investment fund, announced the launch of Autobahn Labs, a novel virtual incubator…
Read More...

Symbiosis Pharmaceutical Services, a specialist provider of pharmaceutical and vaccine development services, has announced it has signed a supply agreement with AstraZeneca for sterile…
Read More...

CSL Behring announced that it has agreed to acquire exclusive global license rights to commercialize an adeno-associated virus (AAV) gene therapy program, AMT-061 (etranacogene…
Read More...

Yumanity Therapeutics announced that it has entered into a strategic research collaboration and license agreement with Merck (known as MSD outside the United States and Canada) focused…
Read More...

NeuroRx, Inc., in partnership with RELIEF THERAPEUTICS Holding AG announced that the U.S. Food and Drug Administration (FDA) awarded Fast Track designation to NeuroRx for the…
Read More...

Replicate Bioscience, Inc. and Immunomic Therapeutics, Inc. announced that the companies have entered into a research and licensing option agreement to combine their platform…
Read More...

Thermo Fisher Scientific and Daiichi Sankyo have expanded their partnership by signing a new agreement to co-develop a companion diagnostic (CDx) that will utilize Thermo Fisher's…
Read More...

Novaremed AG (Novaremed), a clinical-stage Swiss biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug (IND)…
Read More...

Linnaeus Therapeutics, Inc. (Linnaeus) announced that it has entered into a clinical collaboration agreement with Merck to evaluate the combination of its lead investigational product…
Read More...

Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, have agreed to expand their existing 2018…
Read More...

Gilead Sciences, Inc. announced that for $275 million the company will acquire a 49.9 percent equity interest in Pionyr Immunotherapeutics Inc., a privately held company developing…
Read More...

Century Therapeutics announced its acquisition of Empirica Therapeutics to leverage its iPSC-derived allogeneic cell therapies against glioblastoma (GBM). “We are pleased to welcome…
Read More...

Agenus Inc. announced that it has entered into an agreement with Betta Pharmaceuticals, a top Chinese pharmaceutical company focusing on the development of innovative oncology…
Read More...

Sarepta Therapeutics, Inc. and Codiak BioSciences, Inc. announced a global research and option agreement to design and develop engineered exosome therapeutics to deliver gene therapy,…
Read More...

Piramal Enterprises Limited's (PEL) Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), announced that the Company has entered into an…
Read More...

Ascentage Pharma announced a clinical collaboration with Acerta Pharma, the hematology research and development center of excellence of AstraZeneca. Under the terms of the…
Read More...